Preventive and Therapeutic Vaccine

Preventive and Therapeutic Vaccine Market Size, Industry
Analysis Report, Regional Outlook- 2017-2024.: Global
Market Insights Inc.
Global Preventive and Therapeutic Vaccine Market is broadly classified into preventive
vaccine market and therapeutic vaccine market. Based on the product type, preventive
vaccine market is segmented into pediatric and adult vaccines and therapeutic vaccine
is segmented into neurological disease vaccines, autoimmune disease vaccines,
infectious disease vaccines, and cancer vaccines.
Global Preventive and Therapeutic Vaccine Market size is poised to experience high
growth, primarily because of its fast-growing nature and expanding market size.
Vaccine developments have been considerably increasing since recent past and their
adoption is also rising in various regions across the globe. Practices by the major
companies, such as consistent research and innovation and development for
introducing recent technologies to curb expense and reduce time will spur vaccine
market worldwide.
Increasing government funding for vaccine development, rising R&D investments, the
introduction of faster vaccine development technologies, and improvements in vaccine
design are some of the factors, which will fuel market growth over the coming years.
However, the high cost of vaccine storage and transportation and stringent regulations
for the approval of vaccines will hamper the market expansion.
Soaring prevalence of diseases among children is resulting in the implementation of
awareness programs by governments across the globe. Moreover, significant
advancements in vaccinology, such as the emergence, development, and usage of
hepatitis B vaccine, should augment the business growth over the coming years.
Strategies adopted by major vendors in the market, such as the development of
improved influenza vaccine that broaden vaccine-induced immunity, enhancing the
vaccine immunogenicity, and introducing alternative delivery will result in greater
adoption of influenza vaccine in future.
A significant factor proliferating the demand for certain vaccines is high effectiveness;
for example, the experimental shingles vaccine protects about 90% of adults, the
present Zostovax vaccine reduces the risk of shingles by about half and immunity wanes
within five years. In coming years, more vaccines will have better effectiveness and
therefore, these vaccines will experience high adoption rates.
1 | P a g e

Based on the technology type, the vaccine market is segmented into live attenuated,
toxoid, conjugate, inactivated & subunit, and recombinant. The conjugate vaccines
hold the largest market share; the growth of this segment is associated with the massive
government support for vaccine development and rising investments in R&D.
Browse key industry insights from the report “Preventive and Therapeutic Vaccine
Market Size, Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK,
France, Italy, Russia, China, India, Japan, Malaysia, Thailand, Indonesia, Australia, Brazil,
Saudi Arabia, UAE, South Africa), Application Growth Potential, Competitive Market
Growth & Forecast, 2017 – 2024” in detail along with the table of contents:
https://www.gminsights.com/industry-analysis/preventive-and-therapeutic-vaccinemarket
The U.S. preventive and therapeutic vaccine market enjoys the major share because of
the presence of advanced and active R&D establishment. It dominates the therapeutic
vaccine market, which is driven by large pharmaceutical industry base, best-in-class
healthcare infrastructure, and high spending on healthcare by the citizens. The
government support for research and development of vaccines, investments for vaccine
research, and ubiquity of different diseases fuel the growth of this region.
Europe preventive and therapeutic vaccine market is the second largest market after
North America. Research, innovation, and development conducted by MNCs in the field
of vaccine production by utilizing their deep expertise are advantages for this region.
Increasing prevalence of diseases in children and adults will generate demand for more
preventive vaccine in coming years; to cater to this demand, big companies, such as
Pfizer, Merck, Sanofi, and GlaxoSmithKline, will play a key role in the future.
In the APAC preventive and therapeutic vaccine market, the growing incidences of
cancer & HIV cases will give rise to the demand for vaccine and therefore boost the
market growth. Improving healthcare sector, increasing healthcare expenditure, and
government initiatives will render a high impact on adoption rates of vaccines. WHO
estimates a huge potential for the market with the arrival of new improved preventive
and therapeutic vaccines. China and India are expected to witness a boom in demand
and are expected to attain maximum growth over the next 10 years, owing to the
escalating prevalence of various infectious diseases and improving economic
indicators.
Latin America therapeutic vaccines targeting cancers and allergies offer vast
opportunities for fresh players entering this regional market. First FDA-approved
therapeutic vaccine, Provenge by Dendreon, treating prostate cancer acknowledged the
potential of vaccines in therapeutics. In the coming years, it is expected that the industry
will experience improvements in vaccine delivery methodologies, vaccine design,
manufacturing in a large-scale process, and development of personalized vaccines.
2 | P a g e

herapeutic vaccines address the demand for safe and cost-effective drugs for the
treatment of cancer and HIV, fueling the market growth.
Saudi Arabia and South Africa dominates the Middle East & Africa preventive and
therapeutic vaccine market. R&D funding for diseases, such as HIV and cancer, by the
government offers a novel opportunity for the vaccine market. Wide usage of vaccines
includes, inactivated, live attenuated, toxoid, subunit, conjugate, dendritic cell, and
synthetic. Preventive vaccine is the leading type due to high awareness among people.
Some of the major players in the global preventive and therapeutic vaccine market are
Sanofi Pasteur, Merck & Co., Pfizer, and GlaxoSmithKline. The largest players account for
approximately 80% of the global revenue. AstraZeneca, Johnson & Johnson, CSL, and
Emergent Biosolutions are the other notable industry players.
About Global Market Insights:
Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market
research and consulting service provider; offering syndicated and custom research
reports along with growth consulting services. Our business intelligence and industry
research reports offer clients with penetrative insights and actionable market data
specially designed and presented to aid strategic decision making. These exhaustive
reports are designed via a proprietary research methodology and are available for key
industries such as chemicals, advanced materials, technology, renewable energy and
biotechnology.
Contact Us:
Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com
Website: https://www.gminsights.com
3 | P a g e